Portland, Oregon (CaymanMama.com) — Youngsters are not only more susceptible to the swine flu, but now, they are more likely to be harmed by the very injection that is said to help them avoid the harmful flu strand.

The European Medicines Agency, a European drug regulator, issued a caution that young children who have been administered GlaxoSmithKline’s swine flu shot may develop a fever after a second dose.

In a statement issued last week, the organization said that data from the drug maker indicated an increased number of children ranging in age from six months to 3 years developed a fever after their second dose of the Pandemrix vaccine, more so than after the first vaccine.

Young children are also more susceptible to other uncomfortable side effects including muscle pain, drowsiness, and irritability.

According to the AP, “The European regulator recommends children get two doses of swine flu vaccine, though Glaxo says one dose is enough. Glaxo’s vaccine contains an adjuvant, a chemical compound to boost the immune response. It is sold across Europe and Canada.”

Another formulation of GlaxoSmithKline’s H1N1 swine flu vaccine, without the adjuvant, is being distributed in the U.S., however those types of vaccines typically cause more side effects.

No flu vaccines with adjuvants have been licensed in America.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.